AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.
Presented by Gravitee Agent complexity is the insidious shadow lurking inside enterprises right now that needs a light shone on it. That’s because enterprises don't deploy a single agent and watch it run, they deploy fleets, each one calling APIs, ca